Shares of Amarin Corporation plc (AMRN), which touched a 52-week low of $3.95 on March 31, 2020, following an unfavorable ruling in a patent case related to Vascepa, have since gained 38% as of this writing.
from RTT - Biotech https://ift.tt/3dRhnhx
via IFTTT
No comments:
Post a Comment